The application cycle will open in March 2020 and will close July 31, 2020. A Selection Committee (appointed by TGC leadership) will review the applications on a rolling basis, assess their fit with the objectives of TGC, select and invite Round 2 applications, and make final candidate selections. All selection decisions are final.
To get started, please create an account and register your innovative solution on the Transplant Grand Challenge submission site. Applicants from both tracks will submit a letter of interest that includes project title, 300-word project summary describing your transplant innovation, and team description (members and affiliation). Completed letters of interest will be uploaded, as a PDF, to the submission site. The Round 1 selection process will be a rolling selection. If selected, the team lead will be notified and will have five business days to accept or decline an invitation to participate in Round 2.
Round 2 applicants will be invited to complete a comprehensive application. Application details will include detailed description of the solution, project logistics, and budget justification. Full details will be sent to selected applicants. The Round 2 selection process will be a rolling selection. Submission for Round 2 applications closes 11:59 p.m. ET on July 31, 2020. Finalists will be notified no later than August 10, 2020. All selection decisions are final.
After invited Round 2 applications are reviewed, finalists will be chosen to pitch their project at a competition (October 1-2, 2020) to be held in conjunction with the 2020 Starzl Network Annual Meeting in Pittsburgh. Finalists may be asked to provide further information such as a written proposal with a milestone-based budget and timeline that expands on their proposed solution. All finalists must be present for the entire competition in order to be eligible for prizes. There will be no virtual pitching permitted. The pitches will be judged by a panel of experts and winners will be announced on October 2.
The Starzl Network thanks the University of Pittsburgh Clinical and Translational Science Institute for the use of their online submission system. https://ctsi.pitt.edu/